ANEMIA
Prepared by : Mark jayson Barcelona
Anemia is defined as a reduction of the total
circulating red cell mass below normal limits
usually diagnosed based on a reduction in the
Hematocrit (the ratio of packed red cells to total blood
volume)
hemoglobin concentration of the blood to levels that are
below the normal range
Anemia
Classification:
according to underlying mechanism
1.
2.
3.
Blood loss
Increased Red cell destruction
Decrease Red cell production
according to alterations in red cell morphology
Morphologic characteristics providing etiologic clues
red cell size (normocytic, microcytic, or macrocytic);
degree of hemoglobinization, reflected in the color of
red cells (normochromic or hypochromic);
shape.
most useful red cell indices are as follows:
Mean cell volume: the average volume of a red
cell expressed in femtoliters (fL)
Mean cell hemoglobin: the average content
(mass) of hemoglobin per red cell, expressed in
picograms
Mean cell hemoglobin concentration:
the average concentration of
hemoglobin in a given volume of packed
red cells, expressed in g/DL
Red cell distribution width: the
coefficient of variation of red cell
volume
Clinical findings
common complaints
Patients appear pale. Weakness, malaise, and easy
fatigability are
The lowered oxygen content of the circulating
blood leads to dyspnea on mild exertion.
Hypoxia can cause fatty change in the liver,
myocardium, and kidney.
Anemias of Blood Loss
ACUTE BLOOD LOSS
CHRONIC BLOOD LOSS
Acute Blood loss
due to the loss of intravascular volume,
which if massive can lead to
cardiovascular collapse,
shock,
death
Intravascular
shift
It takes about 5 days for
the progeny of these
CFU-Es to mature and
appear as newly released
red cells (reticulocytes)
in the peripheral blood
Rapidly restored by the intravascular shift
of water from the interstitial fluid
compartment.
hemodilution
hemodilution and a lowering
of the hematocrit.
reduction in
oxygenation
increased secretion of
erythropoietin from the
kidney
proliferation
proliferation of
committed
erythroid
progenitors (CFUE) in the marrow
Significant bleeding results in predictable changes in the blood
involving not only red cells, but also white cells and platelets.
If the bleeding is sufficiently massive >> leukocytosis
Initially, red cells appear normal in size and color
(normocytic, normochromic).
as marrow production increases increase in the
reticulocyte count (reticulocytosis), which reaches 10%
to 15% after 7 days.
larger in size than normal red cells (macrocytes)
blue-red polychromatophilic cytoplasm.
Early recovery from blood loss is also often accompanied by
thrombocytosis, which results from an increase in platelet
production.
CHRONIC BLOOD LOSS
anemia only when the rate of
loss exceeds the regenerative capacity of the
marrow
iron reserves are depleted
EX. Gastrointestinal tract lesions, gynecologic
disturbances
Hemolytic Anemias
Features:
A shortened red cell life span below 120 days
Elevated erythropoietin levels and a compensatory
increase in erythropoiesis
Accumulation of hemoglobin degradation products that
recreated as part of the process of red cell hemolysis
Hemolytic anemia
extravascular hemolysis,- premature destruction of red cells also
occurs within phagocytes,
If persistent, extravascular hemolysis leads to a hyperplasia of phagocytes
manifested by varying degrees of splenomegaly.
Extravascular hemolysis is generally
caused by alterations that render the red
cell less deformable.
principal clinical features of extravascular
hemolysis:
anemia, splenomegaly, and jaundice
intravascular hemolysis predominates Intravascular hemolysis of red
cells may be caused by:
mechanical injury,
Manifested by:
Complement fixation,
anemia,
intracellular parasites
hemoglobinemia,
hemoglobinuria,
Exogenous toxic factor
hemosiderinuria, and
Jaundice
Unlike in extravascular hemolysis,
splenomegaly is not seen.
free hemoglobin
released from lysed
red cells
heme groups
-catabolized to bilirubin
within mononuclear
phagocytes
bound by haptoglobin
free hemoglobin
oxidizes to
methemoglobin,
reabsorb and
catabolize hemoglobin
and methemoglobin
some passes out in the
urine, imparting a redbrown color
Iron released from
hemoglobin
>>renal
hemosiderosis.
Jaundice.
MORPHOLOGY
increased numbers of erythroid precursors (normoblasts) in
the marrow
Compensatory increases in erythropoiesis result in a prominent
reticulocytosis in the peripheral blood.
The phagocytosis of red cells leads to the accumulation of the
iron containing pigment hemosiderin
If the anemia is severe, extramedullary hematopoiesis can
appear in the liver, spleen, and lymph nodes.
Hereditary Spherocytosis
Hereditary spherocytosis (HS) is an inherited disorder
caused by intrinsic defects in the red cell membrane
skeleton that render red cells spheroid, less
deformable, and vulnerable to splenic sequestration
and destruction
pathogenesis
HS is caused by diverse mutations that lead to an insuf ciency of
membrane skeletal components.
life span of RBC- 10 to 20 days
The pathogenic mutations most commonly affect
ankyrin,
band 3,
spectrin, or
band 4.2,
this complex is particularly
important in stabilizing the lipid
bilayer.
An autosomal dominant inheritance pattern
is seen in about 75% of cases.
The prevalence of HS is highest in northern
Europe,
1 in 5000 are reported
mutations cause
frameshifts or
introduce
premature stop
codons,
mutated allele fails
to produce any
protein
Deficiency of the
affected protein
reduces the
assembly of the
skeleton as a whole
Young HS red cells are normal in shape, but the destabilized lipid bilayer sheds membrane fragments
destabilizing the
overlying plasma
membrane.
Morphology
The most specific morphologic finding is
spherocytosis, apparent on smears as small, darkstaining (hyperchromic) red cells lacking the central
zone of pallor
Spherocytosis is distinctive but not pathognomonic
Cholelithiasis (pigment stones) occurs in 40% to 50%
of affected adult
Moderate splenomegaly is char chracteristic (5001000 gm)
Clinical feature
The diagnosis is based on family history, hematologic ndings, and
laboratory evidence.
2/3 of the patients the red cells are abnormally sensitive to
osmotic lysis
HS red cells also have an increased mean cell hemoglobin
concentration,
The characteristic clinical features:
anemia,
splenomegaly
jaundice.
HS presents at birth with marked jaundice and requires exchange
transfusions
In 20% to 30% of patients the disease is so mild as to be virtually
asymptomatic
The generally stable clinical course is sometimes punctuated by
aplastic crises, >> acute parvovirus infection
Hemolytic crises are produced by intercurrent events leading to
Splenectomy treats the anemia and its
complications, but brings with it an increased risk
of sepsis
Glucose-6-Phosphate Dehydrogenase
Deciency
Abnormalities in the hexose monophosphate shunt or
glutathione metabolism
hereditary deficiency of glucose-6-phosphate dehydrogenase
(G6PD) activity
Reduce ability of RBC to protect themselves against
oxidative injuries and lead to hemolysis
Two variants with most significant hemolytic
anemia
G6PD (Present in about 10% of American black)
G6PD Mediterranean, (prevalent in the Middle East)
The episodic hemolysis that is characteristic of
G6PD deficiency is caused by exposures that
generate oxidant stress
Trigger :
Infection- most common
viral hepatitis,
pneumonia,
typhoid fever
Drugs
Antimalarials (e.g., primaquine and
chloroquine),
sulfonamides,
nitrofurantoins,
Oxidant
cross linking of
reactive
sulfhydryl groups
on globin chain
Heinz bodies can
damage the membrane
suficiently to cause
intravascular
hemolysis.
become
denatured and
precipitate
As inclusion-bearing
red cells pass through
the splenic cords,
macrophages pluck out
the Heinz bodies.
formation of
Heinz bodies
Some cells retain an
abnormal shape,
appearing to have a
bite taken out of
them
Acute intravascular hemolysis, marked by anemia,
hemoglobinemia, and hemoglobinuria, usually begins 2 to 3 days
following exposure of G6PD-deficient individuals to oxidants
The hemolysis is greater in individuals with the highly unstable
G6PD Mediterranean variant.
Because hemolytic episodes related to G6PD deficiency occur
intermittently, features related to chronic hemolysis (e.g.,
splenomegaly, cholelithiasis) are absent.
Sickle cell anemia
a common hereditary hemoglobinopathy caused by a point
mutation in -globin
promotes the polymerization of deoxygenated hemoglobin,
leading to red cell distortion, hemolytic anemia, microvascular
obstruction, and ischemic tissue damage
Hemoglobin is a tetrameric protein
composed of two pairs of globin
chains, each with its own heme
group
Normal adult red cells contain
mainly HbA (22), along with
small amounts of HbA2 (22),
fetal hemoglobin (HbF; 22).
Sickle cell disease is caused by a point mutation in the sixth codon
of -globin that leads to the replacement of a glutamate residue
with a valine residue
roughly 2 million individuals, are
heterozygous for HbS, a largely
asymptomatic condition known as
sickle cell trait.
The off- spring of two
heterozygotes has a 1 in 4 chance
of being homozygous for the sickle
mutation, a state that produces
symptomatic sickle cell disease. In
such individuals, almost all the
hemoglobin in the red cell is HbS
(2S2)
Pathogenesis
The major pathologic manifestations
chronic hemolysis,
microvascular occlusions, and
tissue damage
stem from the tendency of HbS
molecules to stack into polymers
when deoxygenated
Initially, this process converts the red cell cytosol from a
freely owing liquid into a viscous gel.
With continued deoxygenation HbS molecules assemble
into long needle-like fibers within red cells, producing a
distorted sickle or holly-leaf shape.
Several variables affect the rate and degree of sickling:
Interaction of HbS with the other types of hemoglobin in the
cell.
Mean cell hemoglobin concentration (MCHC).
Higher HbS concentrations increase the probability that aggregation and
polymerization will occur during any given period of deoxygenation.
Intracellular pH. A decrease in pH
reduces the oxygen af nity of hemoglobin, thereby increasing the fraction of deoxygenated
HbS at any given oxygen tension and augmenting the tendency for sickling
Mechanism of red cell damage
As HbS polymers grow, they herniate through the membrane skeleton and
project from the cell ensheathed by only the lipid bilayer
This severe derangement in membrane structure causes the in ux of Ca2+
ions, which induce the cross-linking of membrane proteins
With repeated episodes of sickling, red cells become increasingly
dehydrated, dense, and rigid
Eventually, the most severely damaged cells are converted to end-stage,
nondeformable, irreversibly sickled cells, which retain a sickle shape even
when fully oxygen- ated
Most serious clinical feature- microvascular occlusions
sickle red cells express higher than normal levels of adhesion
molecules and are sticky.
Microvascular occlusions are not related to the number of
irreversibly sickled cells in the blood, but instead may be
dependent upon more subtle red cell membrane damage and local
factors,
such as inflammation or vasoconstriction, that tend to slow or arrest the
movement of red cells through microvascular beds
Morphology
In sickle cell anemia, the peripheral blood demonstrates variable
numbers of irreversibly sickled cells, reticulocytosis, and
target cells, which result from red cell dehydration
Howell-Jolly bodies (small nuclear remnants) are also present in
some red cells due to the asplenia
The bone marrow is hyperplastic as a result of a compensatory
erythroid hyperplasia.
Morphology
expansion of the marrow leads to bone resorption and
secondary new bone formation, resulting in
prominent cheekbones and changes in the skull that
resemble a crewcut on x-ray studies
Extramedullary hematopoiesis can also appear. The
increased breakdown of hemoglobin can cause
pigment gallstones and hyperbilirubinemia.
Morphology
In early childhood, the spleen is enlarged up to 500 gm by
red pulp congestion
Infarctions caused by vascular occlusions can occur
in many other tissues as well,
bones,
brain,
kidney,
liver, retina, and pulmonary vessels, the latter sometimes
producing cor pulmonale.
In adult patients, vascular stagnation in subcutaneous
tissues often leads to leg ulcers; this complication is
rare in children.
Clinical Features
Sickle cell disease causes a moderately severe
hemolytic anemia (hematocrit 18% to 30%)
Associated with reticulocytosis,
hyperbilirubinemia, and the presence of
irreversibly sickled cells.
Its course is punctuated by a variety of crises.
Vasoocclusive crises, also called pain crises
The most common sites -bones, lungs, liver, brain,
spleen, and penis
In children- painful bone crises are extremely
common and often difFIcult to distinguish from
acute osteomyelitis.
frequently manifest as the hand-foot syndrome or
dactylitis of the bones of the hands or feet, or
both
Acute chest syndrome is a particularly dangerous type of
vaso-occlusive crisis involving the lungs,
typically presents with fever, cough, chest pain, and pulmonary
infilltrates.
Priapism affects up to 45% of males after puberty and may lead
to hypoxic damage and erectile dysfunction
Other disorders related to vascular obstruction, - stroke and
retinopathy leading to loss of visual acuity and even blindness,
Sequestration crises. -massive entrapment of sickle red cells leads
to rapid splenic enlargement, hypovolemia, and sometimes shock.
Both sequestration crises and the acute chest syndrome may be
fatal and sometimes require prompt treatment with exchange
transfusions.
Aplastic crises -stem from the infection of red cell progenitors by
parvovirus B19
chronic hypoxia is responsible for a generalized
impairment of growth and development, as well
as organ damage affecting the spleen, heart,
kidneys, and lung
Sickling provoked by hypertonicity in the renal
medulla causes damage that eventually leads to
hyposthenuria
Diagnosis
The diagnosis is suggested by the clinical findings and
the presence of irreversibly sickled red cells
confirmed by various tests for sickle hemoglobin
involve mixing a blood sample with an oxygen- consuming
reagent, such as metabisulfate, which induces sickling of red
cells if HbS is present
Hemoglobin electro- phoresis is also used to demonstrate the
presence of HbS and exclude other sickle syndromes, such as
HbSC disease.
Prenatal diagnosis is possible by analysis of fetal DNA obtained
by amniocentesis or chorionic biopsy.
Prognosis
The outlook for patients with sickle cell disease
has improved considerably over the past 10 to 20
years.
About 90% of patients survive to age 20, and close to
50% survive beyond the fth decade